Abstract
Lithium (Eskalith® and others), a naturally occurring salt, has been used for various medical purposes since the 1800s. Initially, it was given to patients who suffered from urinary calculi and gout. Later, it was combined with bromides and used as a sedative. In 1949, Cade observed that lithium calmed agitated psychotic patients: ten manic patients responded, six schizophrenic and chronically depressed psychotic patients did not, and one patient’s symptoms reappeared after lithium was stopped.1 During this same period, lithium was introduced in the United States as a salt substitute for cardiac patients, but it caused numerous toxic reactions and several deaths. Thus, even with the emergence of convincing evidence that lithium was safe and effective in manic depressive illness, it was not accepted in the United States until 1970.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cade J. F. J.: Lithium salts in the treatment of psychotic excitement. Med J Aust 11:349–352, 1949.
Davis J. M.: Overview: Maintenance therapy in psychiatry: II. Affective disorders. Am J Psychiatry 133:1–13, 1976.
Forn J., Valdecasas F. G.: Effects of lithium on brain adenyl cyclate activity. Biochem Pharmacol 20:2773–2779, 1971.
Gjessing L. R.: Lithium citrate loading of a patient with periodic catatonia. Acta Psychiatr Scand 43:372–375, 1967.
Kline N. S., Wren J. C., Cooper T. B., et al: Evaluation of lithium therapy in chronic and periodic alcoholism. Am J Med Sci 268:15–22, 1974.
Rifkin A., Quitkin F., Carrillo R., et al: Lithium carbonate in emotionally unstable character disorder. Arch Gen Psychiatry 27:519–522, 1972.
Gottfries C. G.: The effect of lithium salts on various kinds of psychiatric disorders. Acta Psychiatr Scand [Suppl] 203:157–167, 1968.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed revised (DSM-IIIR). Washington, American Psychiatric Association, 1987.
Nurnberger J R., Roose S. P., Dunner D. L., et al: Unipolar mania: A distinct clinical entity? Am J Psychiatry 136:1420–1423, 1979.
Keller M. B., Lavori P. W., Coryell W., et al.: Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 255:3138–3142, 1986.
Winokur G., Clayton P. J., Reich T.: Manic Depressive Disease. St. Louis, C. V. Mosby, 1969.
Weissman M. M., Leaf P. J., Livingston B. M., et al.: The epidemiology of dysthymia in the community: Rates, risks, comorbidity and treatment. 140th Annual Meeting of the American Psychiatric Association, Chicago, American Psychiatric Association, 1987.
Medical Practice Project: A State-of-the-Science Report for the Office of the Assistant Secretary for the U. S. Department of Health, Education and Welfare. Baltimore, Policy Research, 1979.
Fieve R. R.: The lithium clinic: A new model for the delivery of psychiatric services. Am. J Psychiatry 132:1018–1022, 1975.
Garfinkel P. E., Stancer H. C., Persad E.: A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 2:279–288, 1980.
Prien R. F., Caffey E. M. Jr, Klett C. J.: Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiatry 26:146–152, 1972.
Fieve R. R.: Overview of therapeutic and prophylactic trials with lithium in psychiatric patients, in Gershon S., Shopsin B. (eds): Lithium. Its Role in Psychiatric Research and Treatment. New York, Plenum Press, 1973, p 336.
VanPutten T.: Why do patients with manic-depressive illness stop their lithium? Compr Psychiatry 16:179–183, 1975.
Cooper T. B.: Pharmacokinetics of lithium, in Meltzer H. Y. (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1365–1376.
Schou M., Anderson A., Eskajaer-Jensen S., et al .: Occurrence of goiter during lithium treatment. Br J Med 3:710–713, 1968.
Emerson C. H., Dyson W. L., Utiger R. D.: Serum thyrotropin and thyroxin concentration in patients receiving lithium carbonate. J Clin Endocrinol Metab 36:338–346, 1973.
Jefferson J. W.: Lithium carbonate-induced hypothyroidism-its many faces. JAMA 242:271–272, 1979.
VanderVelde C. D., Gordon M. W.: Manic-depressive illness, diabetes mellitus and lithium carbonate treatment. Arch Gen Psychiatry 21:478–485, 1969.
Mellerup E. T., Plenge P., Rafaelson O. J. : Renal and other controversial adverse effects of lithium, in Meltzer H. Y. (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1443–1448.
Gelenberg A. J.: Lithium-induced polyuria: Approaches to management. Biol Ther Psychiatry Newslett 6:17–19, 1983.
Gelenberg A. J., Wojcik J. D., Falk W. E., et al: Effects of lithium on the kidney. Acta Psychiatr Scand 75:29–34, 1987.
Gelenberg A. J.: Lithium and the nephrotic syndrome. Biol Ther Psychiatry 12:24, 1989.
Shopsin B., Gershon S.: Pharmacology-toxicology of the lithium ion, in Gershon S., Shopsin B. (eds): Lithium: Its Role in Psychiatric Research and Treatment. New York, Plenum Press, 1973, pp 107–146.
Schou M.: Electrocardiographic changes during treatment with lithium and with drugs of the imipramine type. Acta Psychiatr Scand [Suppl] 169:258–259, 1963.
Roose S. P., Nurnberger J. L., Dunner D. L., et al: Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry 136:804–806, 1979.
Jaffe C. M.: First-degree atrioventricular block during lithium carbonate treatment. Am J Psychiatry 134:88–89, 1977.
Worthley L. J. C.: Lithium toxicity and refractory cardiac arrhythmia treated with intravenous magnesium. Anesth Intens Care 2:357–360, 1974.
Jefferson J. W., Greist J. H. : Adverse reactions—neurological tremor, in Jefferson, J. W., Greist, J. H. (eds): Primer of Lithium Therapy. Baltimore, Williams & Wilkins, 1977, pp 139–150.
Ghandirian A. M., Lehman H. E.: Neurological side effects of lithium: Organic brain syndrome, seizures, extrapyramidal side effects, and EEG changes. Compr Psychiatry 21:327–335, 1980.
Vestergaard P., Amdison A., Schou M.: Clinically significant side effects of lithium treatment: A survey of 237 patients in long-term treatment. Acta Psychiatr Scand 62:193–200, 1980.
Schou M.: Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 70:594–602, 1984.
Gelenberg A. J., Kane J. M., Keller M. B., Lavori P., Rosenbaum J. F., Cole K., Lavelle J.: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321:1489–1493, 1989.
Donaldson S. R., Gelenberg A. J., Baldessarini R. J.: The pharmacologic treatment of schizophrenia: A progress report. Schizophrenia Bull 9:504–527, 1983.
Prien R. F., Gelenberg A. J.: Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry 146:840–848, 1989.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gelenberg, A.J., Schoonover, S.C. (1991). Bipolar Disorder. In: Gelenberg, A.J., Bassuk, E.L., Schoonover, S.C. (eds) The Practitioner’s Guide to Psychoactive Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1137-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1137-0_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1139-4
Online ISBN: 978-1-4757-1137-0
eBook Packages: Springer Book Archive